Next Sequence accelerate and invest globally in start-ups from the #TechBio ecosystem through a 6-12 accelerator program taking them from 0 to 1 in leveraging AI and Quantum Computing. Our mission is to contribute to the development of the most disruptive companies who want to enable humanity to face up to its next challenges as a species, from fighting genetically transmitted diseases and pandemics to preventing ageing and climate change.
| Website | https://www.thenextsequence.com/ |
| Employees | 14 (5 on RocketReach) |
| Industry | Venture Capital and Private Equity Principals |
| Keywords | Seed Stage Investing, Early Stage Investing, Ai In Healthcare, Accelerator Program, Startup Investment, Biotechnology Investment, Healthcare Technology, Biotech Startups, Ai Startups |
| Competitors | Amgen, Adaptive Biotechnologies Corp., Intellia Therapeutics, Inc., CRISPR Therapeutics, bluebird bio, Editas Medicine, Zymeworks Inc., Allogene Therapeutics, Sangamo Therapeutics, Inc., Cellectis +41 more (view full list) |
Looking for a particular Next Sequence® employee's phone or email?
Next Sequence® Questions
Jason Roper is the Partner of Next Sequence®.
5 people are employed at Next Sequence®.
Top Next Sequence® Employees
-
Jason Roper
Partner at Next Sequence®
Austin, TX, US55+ -
12
-
Sydney Williams
Venture Capital Associate at Next Sequence®
California, United States1 -
Simran Chhabria
Venture Associate at Next Sequence®
Jersey City, NJ, US2
Related Companies
G2Crowd Trusted
300K+
Plugin Users
